659 / 1241
Distant metastasis
Stage II-III, prior to NAC, comparison with standard-of-care
(n=154)
• FDG PET/CT hanging breast + supine body
• X-thorax + US liver + bone scan
Diagnostic value
• Sensitivity 100 %
• Specificity 96 %
Clinical impact of adding FDG PET/CT
• 42 lesions detected in 25 patients
• 13% of patiens change of treatment
18F-FDG PET/CT as a staging procedure in primary stage II and III breast
cancer: comparison with conventional imaging techniques. Koolen BB et al.
Breast Cancer Res Treat. 2012 Jan;131(1):117-26.
27